Mitochondrial peptides: MOTS-c and SS-31

Mitochondrial-derived peptides (MDPs) are short peptides encoded within the mitochondrial genome rather than the nuclear genome. MOTS-c and Humanin are the most studied members and feature widely in metabolic and mitochondrial-biology research as endogenous signalling molecules.

What mitochondrial-derived peptides are

Mitochondrial-derived peptides are a class of small bioactive peptides whose coding sequences reside inside the mitochondrial DNA rather than in the nucleus. They are translated from short open reading frames embedded within the mitochondrial ribosomal RNA genes. Humanin, a 24-amino-acid peptide, was the first to be characterized and is encoded within the 16S rRNA region. MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded within the 12S rRNA gene. Because their sequences originate from the organelle's own genome, MDPs are considered part of a retrograde signalling system through which mitochondria communicate their functional state to the rest of the cell and, potentially, to distant tissues. In research literature they are frequently described as a window into mitochondrial-to-nuclear communication, and as evidence that the mitochondrial genome encodes regulatory signals beyond the classic respiratory-chain subunits. Their discovery has broadened how researchers conceptualize the organelle, treating it not only as a site of energy production but also as a source of endocrine-like and autocrine signalling molecules. Peptiko supplies MOTS-c strictly as a reference reagent for in-vitro and laboratory research conducted by qualified investigators, with no human or animal application implied.

MOTS-c and AMPK signalling

MOTS-c is the mitochondrial-derived peptide most associated with cellular energy-sensing research. In cell and tissue models, investigators report that MOTS-c influences the AMP-activated protein kinase (AMPK) pathway, a central regulator of energy homeostasis that becomes active when cellular energy charge falls. Mechanistic studies describe MOTS-c interacting with the folate-methionine one-carbon metabolic cycle, with downstream accumulation of AICAR proposed as one route to AMPK activation. Through AMPK, the literature examines effects on glucose uptake, fatty-acid handling and metabolic flexibility in cultured cells. These observations have made MOTS-c a recurring probe in studies of insulin signalling, mitochondrial function and metabolic adaptation under nutrient and exercise-mimetic stress in laboratory systems. Researchers also use it to interrogate how an endogenously encoded peptide can act as a metabolic regulator that responds to the cell's energy state. All such findings derive from in-vitro assays and animal models reported in the scientific literature and are presented here only as mechanistic research context. Nothing here describes effects in humans, and the peptide is offered exclusively for laboratory research use.

Nuclear translocation under metabolic stress

A distinctive feature reported for MOTS-c is its capacity to relocate from the cytoplasm to the cell nucleus when cells are placed under metabolic stress, such as glucose restriction or oxidative challenge in culture. Research describes this translocation as dependent on AMPK activity, after which MOTS-c is reported to associate with stress-responsive transcription factors, including members of the NRF2 antioxidant-response and nuclear factor family pathways. Through these interactions, studies propose that MOTS-c helps regulate the expression of nuclear genes involved in antioxidant defence and metabolic homeostasis, effectively allowing a mitochondrially encoded peptide to influence the nuclear transcriptional program. This positions MOTS-c within the broader concept of mitochondrial retrograde signalling, where the organelle's status feeds back to coordinate the cell's adaptive response. The translocation behaviour also makes MOTS-c a useful experimental marker for studying how energy stress is sensed and converted into changes in gene expression. These mechanisms are documented in cell-based and animal experimental systems and are summarized strictly as research context, not as guidance for any human or animal use.

Humanin and mitochondrial-biogenesis research

Humanin, the founding member of the MDP family, is studied in laboratory models for cytoprotective and metabolic signalling. Research literature describes Humanin interacting with cell-surface receptor complexes and modulating apoptotic signalling pathways in cultured cells, which has made it a frequent subject in studies of cellular stress resistance. Alongside MOTS-c, Humanin appears in investigations of mitochondrial biogenesis, the process by which cells expand their mitochondrial network, often examined through markers such as PGC-1-alpha and downstream respiratory-chain components in experimental systems. Both peptides are also used as analytes in research on circulating MDP levels, where mass spectrometry and immunoassays quantify them as candidate indicators of mitochondrial function in biological samples. For laboratories, accurate identity and purity verification by HPLC-MS and a Certificate of Analysis are essential when using these peptides as reference standards, since sequence fidelity directly affects experimental reproducibility. Together, MOTS-c and Humanin illustrate how a small set of mitochondrially encoded peptides has reshaped research into metabolic signalling and organelle communication. Peptiko supplies these compounds for in-vitro and laboratory research only, with no therapeutic, diagnostic or consumer application.

Related guides

Peptide regulations in the EU How to verify a Janoshik COA How to choose a research peptide supplier